Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Durvalumab + Pomalidomide +/- Dexamethasone for Multiple Myeloma
Recruiting3 awardsPhase 1
Boston, Massachusetts
This trial is studying a combination of drugs as a possible treatment for multiple myeloma. A partial clinical hold has been placed on the trial by the FDA based on data related to risks of one of the drugs in the combination in patients with multiple myeloma.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.